Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease

Andrea Caddeo, Stefano Romeo

Clin Mol Hepatol. 2025;31(Suppl):S76-S93. Published online August 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0438

View: 9076 Download: 498 Web of Science: 13 Crossref: 17

Prospects of late-stage development agents in the treatment of metabolic dysfunction-associated steatohepatitis

Brian Lee, Ussama Ghumman, Lisa D. Pedicone, Andres Gomez Aldana, Eric Lawitz

Clin Mol Hepatol. 2025;31(4):1167-1196. Published online August 4, 2025

DOI: https://doi.org/10.3350/cmh.2025.0337

View: 3654 Download: 191

Correspondence

GOLM1 and bile acid synthesis: Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”

Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen

Clin Mol Hepatol. 2025;31(2):e189-e191. Published online February 13, 2025

DOI: https://doi.org/10.3350/cmh.2025.0120

View: 3961 Download: 31 Crossref: 1

Correspondence to letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”

Yuri Cho, Dae Won Jun

Clin Mol Hepatol. 2025;31(1):e103-e104. Published online September 24, 2024

DOI: https://doi.org/10.3350/cmh.2024.0818

View: 3183 Download: 43

Correspondence to editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”

Amal Magdy, Hee-Jin Kim, Won Kim, Mirang Kim

Clin Mol Hepatol. 2025;31(1):e70-e73. Published online September 10, 2024

DOI: https://doi.org/10.3350/cmh.2024.0761

View: 3309 Download: 82

Correspondence to editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy”

Qi Wang, Qingfa Bu, Haoming Zhou, Ling Lu

Clin Mol Hepatol. 2024;30(4):1026-1027. Published online July 8, 2024

DOI: https://doi.org/10.3350/cmh.2024.0470

View: 3129 Download: 57

Original Article

DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease

Amal Magdy, Hee-Jin Kim, Hanyong Go, Jun Min Lee, Hyun Ahm Sohn, Keeok Haam, Hyo-Jung Jung, Jong-Lyul Park, Taekyeong Yoo, Eun-Soo Kwon, Dong Hyeon Lee, Murim Choi, Keon Wook Kang, Won Kim, Mirang Kim, on behalf of the Innovative Target Exploration of NAFLD (ITEN) Consortium

Clin Mol Hepatol. 2024;30(4):824-844. Published online July 25, 2024

DOI: https://doi.org/10.3350/cmh.2024.0229

View: 6110 Download: 364 Web of Science: 7 Crossref: 6

Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis

Juchul Hwang, Hyeyoung Hwang, Hyunjae Shin, Bo Hyun Kim, Seong Hee Kang, Jeong-Ju Yoo, Mi Young Choi, Dong eun Lee, Dae Won Jun, Yuri Cho

Clin Mol Hepatol. 2024;30(3):561-576. Published online June 3, 2024

DOI: https://doi.org/10.3350/cmh.2023.0384

View: 8700 Download: 199 Web of Science: 19 Crossref: 23

Editorial

The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective

Carlos Jose Pirola, Silvia Sookoian

Clin Mol Hepatol. 2024;30(2):174-176. Published online February 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0082

View: 4945 Download: 91 Web of Science: 2 Crossref: 2

Review Article

Panomics in MASLD: Unravelling the drivers of disease heterogeneity

Carlos José Pirola, Silvia Sookoian

Received August 27, 2025 Accepted October 25, 2025

DOI: https://doi.org/10.3350/cmh.2025.0960 [Accepted]

View: 273 Download: 16

1 |

Viewed By 19883	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 15744	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 11168	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 11135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 9282	MAFLD: How is it different from NAFLD?

Cited By 434	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 420	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 278	MAFLD: How is it different from NAFLD?
Cited By 206	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Cited By 148	Non-alcoholic fatty liver disease: Definition and subtypes

Search